Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Latest filing published 20 Mar 2026 for Kymera Therapeutics, Inc., €106k.
Filing timeline
BuySalePamela Esposito
Insider track record
Disclosed buys
0
Disclosed sells
5
Signal history
Pamela Esposito: trading record in brief
Pamela Esposito, listed as senior executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Replimune Group, Inc. and Kymera Therapeutics, Inc. We count 29 filings; the first trade dates from 13 December 2018 and the latest from 20 March 2026.
On the market, this insider has only sold: 5 sales, €710k in total. Outside the open market, there are 2 share grants and 22 option exercises.
Most recently, on 20 March 2026, the filings show an option exercise worth €106k in Kymera Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Pamela Esposito
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations29 total
2,500 shares@ US$49.10100.0% of flowCommon StockSEC:0001193125-26-118032:0
2,500 shares@ US$49.109.2% of flowCommon StockSEC:0001193125-26-061686:0
3,000 shares@ US$31.207.1% of flowCommon StockSEC:0001193125-26-016934:0
12,563 shares@ US$49.1046.2% of flowCommon StockSEC:0001193125-25-323090:0
5,000 shares@ US$29.5511.4% of flowCommon StockSEC:0000950170-25-081201:0
2,500 shares@ US$29.556.2% of flowCommon StockSEC:0000950170-24-132401:0
8,500 shares@ US$29.5519.9% of flowCommon StockSEC:0000950170-24-107458:0
5,358 shares@ US$3.304.7% of flowCommon StockSEC:0001104659-23-100560:0
13,600 shares@ US$3.3011.8% of flowCommon StockSEC:0001104659-23-094997:0
1,400 shares@ US$3.301.2% of flowCommon StockSEC:0001104659-23-092111:0
15,000 shares@ US$3.3012.9% of flowCommon StockSEC:0001104659-23-080113:0
5,966 shares@ US$18.0528.4% of flowCommon StockSEC:0001104659-23-062372:0
40,000 shares0Common StockSEC:0001104659-23-041727:0
15,000 shares@ US$1.014.1% of flowCommon StockSEC:0001104659-22-126741:0
3,507 shares@ US$14.5914.0% of flowCommon StockSEC:0001104659-22-062610:0
22,750 shares0Common StockSEC:0001104659-22-042762:0
4,200 shares@ US$15.5015.7% of flowCommon StockSEC:0001104659-21-101719:0
4,862 shares@ US$1.011.2% of flowCommon StockSEC:0001104659-21-095084:0
20,000 shares@ US$1.014.8% of flowCommon StockSEC:0001104659-21-093670:0
4,600 shares@ US$1.011.1% of flowCommon StockSEC:0001104659-21-093671:0
50,704 shares@ US$1.757.0% of flowCommon StockSEC:0001104659-20-139951:0
12,590 shares@ US$3.303.3% of flowCommon StockSEC:0001104659-20-135903:0
16,000 shares@ US$1.011.3% of flowCommon StockSEC:0001104659-20-115710:0
7,000 shares@ US$30.1517.4% of flowCommon StockSEC:0001104659-20-115710:1
9,000 shares@ US$35.0425.9% of flowCommon StockSEC:0001104659-20-115710:2
25 of 29 declarations
